Outcomes of triple-negative versus non-triple-negative breast cancers managed with breast-conservative therapy

被引:0
|
作者
Bhatti, Abu Bakar Hafeez [1 ]
Khan, Amina Iqbal [1 ]
Siddiqui, Neelam [1 ]
Muzaffar, Narjis [1 ]
Shah, Mazhar Ali [1 ]
机构
[1] Shaukat Khanum Mem Canc Hosp & Reserach Ctr, Lahore, Pakistan
关键词
D O I
10.1200/jco.2013.31.26_suppl.70
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
70
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Comparative antiproliferative effects of iniparib and olaparib on a panel of triple-negative and non-triple-negative breast cancer cell lines
    Pierce, Aisling
    McGowan, Patricia M.
    Cotter, Maura
    Mullooly, Maeve
    O'Donovan, Norma
    Rani, Sweta
    O'Driscoll, Lorraine
    Crown, John
    Duffy, Michael J.
    CANCER BIOLOGY & THERAPY, 2013, 14 (06) : 537 - 545
  • [42] COMPARISON OF CLINICO-PATHOLOGICAL FEATURES AND PROGNOSIS OF TRIPLE-NEGATIVE AND NON-TRIPLE-NEGATIVE FEMALE BREAST CANCER PATIENTS
    Chellappan, Nonam
    Raj, Smitha G.
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (30): : 3412 - 3418
  • [43] Is Breast Conservation Therapy Superior to Mastectomy for Women With Triple-Negative Breast Cancers?
    Pignol, Jean-Philippe
    Rakovitch, Eileen
    Olivotto, Ivo A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (21) : 2841 - 2843
  • [44] Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
    Xiaoxian Li
    Jing Yang
    Limin Peng
    Aysegul A. Sahin
    Lei Huo
    Kevin C. Ward
    Ruth O’Regan
    Mylin A. Torres
    Jane L. Meisel
    Breast Cancer Research and Treatment, 2017, 161 : 279 - 287
  • [45] Comparison of the expression levels of lysine-specific demethylase 1 and survival outcomes between triple-negative and non-triple-negative breast cancer
    Zhao, Kangrong
    Li, Yanlin
    Han, Tiantian
    Sun, Aiqin
    Bian, Wenxuan
    Li, Mingyue
    Lin, Qiong
    Shao, Genbao
    ONCOLOGY LETTERS, 2021, 21 (02)
  • [46] Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
    Li, Xiaoxian
    Yang, Jing
    Peng, Limin
    Sahin, Aysegul A.
    Huo, Lei
    Ward, Kevin C.
    O'Regan, Ruth
    Torres, Mylin A.
    Meisel, Jane L.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (02) : 279 - 287
  • [47] Prevalence of germline mutations in genes engaged in DNA damage repair by homologous recombination in patients with triple-negative and hereditary non-triple-negative breast cancers
    Domagala, P.
    Jakubowska, A.
    Jaworska-Bieniek, K.
    Kaczmarek, K.
    Durda, K.
    Kurlapska, A.
    Cybulski, C.
    Lubinski, J.
    VIRCHOWS ARCHIV, 2015, 467 : S165 - S166
  • [48] Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers
    Domagala, Pawel
    Jakubowska, Anna
    Jaworska-Bieniek, Katarzyna
    Kaczmarek, Katarzyna
    Durda, Katarzyna
    Kurlapska, Agnieszka
    Cybulski, Cezary
    Lubinski, Jan
    PLOS ONE, 2015, 10 (06):
  • [49] HSET Expression in Triple Negative and Non-Triple Negative Breast Cancers
    Oprea-Ilies, G. M.
    Pannu, V.
    Liu, Y.
    Nickleach, D.
    Pambuccian, S. E.
    Aneja, R.
    LABORATORY INVESTIGATION, 2013, 93 : 60A - 60A
  • [50] HSET Expression in Triple Negative and Non-Triple Negative Breast Cancers
    Oprea-Ilies, G. M.
    Pannu, V.
    Liu, Y.
    Nickleach, D.
    Pambuccian, S. E.
    Aneja, R.
    MODERN PATHOLOGY, 2013, 26 : 60A - 60A